Rakuten Medical Stock
HealthTechLooking to sell Rakuten Medical stock or options?
Eligible for:
Charitable Exchange Fund
Rakuten Medical specializes in developing precision-targeted cancer therapies intended to treat solid tumors. Their unique treatments comprise a cancer-targeting monoclonal antibody fused to a photoactivatable molecule that acquires anticancer properties when activated by light at the tumor location. This offers patients with recurrent head and neck cancer access to oncologic drugs that quickly kill cancer cells without damaging the surrounding healthy tissues.
Investors Include:
General Catalyst, ABC Partners, Hiroshi Mikitani, Rakuten Group, SBI Holdings, Rakuten Capital.